Trial
NCT03585764
MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
National Cancer Institute (NCI); OvaCure Fundation; Alliance for Cancer Gene Therapy; Ovarian Cancer Alliance of Greater Cincinnati
Condition
Ovarian Cancer
Intervention
MOv19-BBz CAR T cells
Why stopped
This study was halted prematurely due to recruitment barriers
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-26